-
1 Comment
BioLife Solutions, Inc is currently in a long term uptrend where the price is trading 33.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.5.
BioLife Solutions, Inc's total revenue rose by 77.5% to $15M since the same quarter in the previous year.
Its net income has increased by 82.6% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 156.4% to $-3M since the same quarter in the previous year.
Based on the above factors, BioLife Solutions, Inc gets an overall score of 4/5.
Industry | Medical Instruments & Supplies |
---|---|
Sector | Healthcare |
ISIN | US09062W2044 |
CurrencyCode | EUR |
Exchange | F |
Market Cap | 838M |
---|---|
Beta | 1.85 |
Dividend Yield | 0.0% |
Target Price | 62.14 |
PE Ratio | None |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BJX1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024